MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-04-0018998
Primus Medident Private Limited
Primus Medident Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹31.42 Lakh
▲ 28% YoY
Net profit · FY 2024
₹1.04 Lakh
Net margin 3.3%
EBITDA · FY 2024
₹1.53 Lakh
EBITDA margin 4.9%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Primus Medident Private Limited
Data last updated:
Primus Medident Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the nursing segment of the healthcare sector. It was incorporated on 15 January 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2009PTC186701.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mahinder Singh and Garima Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 125 Vardhman Plus City Mall Sector – 23 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.42 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Lakh (net margin 3.3%) and EBITDA of ₹1.53 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 13% over five years.
Primus Medident Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0018998). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100DL2009PTC186701
Registration Number 186701
Incorporation Date 15 January 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-04-0018998
Recognitions & Rankings of Primus Medident
Contact details
Primus Medident Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address125 Vardhman Plus City Mall Sector – 23 Dwarka, New Delhi, Delhi, India – 110075
- IndustryHealthcare, Nursing, Pathology, Dentalcare
To see the full contact details of Primus Medident Private Limited, buy the company report.
Comprehensive company report
Primus Medident Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Primus Medident is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Primus Medident Private Limited, buy the company report.
Financials of Primus Medident Private Limited
FY 2025 filings availablePrimus Medident Private Limited reported revenue of ₹31.42 Lakh (up 28% YoY) for FY 2024.
Revenue · FY 2024
₹31.42 Lakh ▲ 28%
Net profit · FY 2024
₹1.04 Lakh margin 3.3%
EBITDA · FY 2024
₹1.53 Lakh margin 4.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 25%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 4%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 28% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Primus Medident Private Limited, buy the company report.
Board of directors of Primus Medident Private Limited
Primus Medident has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahinder Singh Also directs: Primus Agriprojects Private Limited, Dentistico Private Limited | Director | 15 Jan 2009 | 17 Years 9 Months | Current |
| Garima Yadav Also directs: Primus Agriprojects Private Limited, Dentistico Private Limited | Director | 15 Jan 2009 | 17 Years 9 Months | Current |
| Vaibhav Yadav | Director | 25 Feb 2017 | 9 Years 7 Months | Current |
Peer comparison
Primus Medident Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Total Health Pharmaceuticals Private Limited | ₹32.61 Lakh (FY 2021) | -55.0% | New Delhi, Delhi, India | |||
| Maurya Diagnostic Centre Private Limited | ₹32.61 Lakh (FY 2025) | 3.0% | Gaya, Bihar, India | |||
| Sushrutha Facio Maxillary Services Private Limited | ₹32.55 Lakh (FY 2016) | 5.0% | Hyderabad, Telangana, India | |||
| Leopath Wellness Labs Private Limited | ₹32.41 Lakh (FY 2024) | 16.0% | Dehradun, Uttarakhand, India | |||
| Sequel Diagnostic Services Private Limited | ₹32.34 Lakh (FY 2022) | 95.0% | Gurgaon, Haryana, India | |||
| Primus Medident Private Limitedthis company | ₹31.42 Lakh (FY 2024) | ₹1.04 Lakh | 3.3% | 28.0% | New Delhi, Delhi, India | |
| Monk Medisolutions Private Limited | ₹31.35 Lakh (FY 2025) | -66.0% | Delhi, India | |||
| Pikale Healthcare Private Limited | ₹31.33 Lakh (FY 2025) | 85.0% | Mumbai, Maharashtra, India | |||
| Prakash Maternity Centre Private Limited | ₹31.14 Lakh (FY 2025) | 20.0% | Patna, Bihar, India | |||
| Cassiopeia Pharmaceuticals Private Limited | ₹31.08 Lakh (FY 2024) | 21.0% | Lucknow, Uttar Pradesh, India | |||
| Malwa Diagnostics Private Limited | ₹30.98 Lakh (FY 2024) | 6.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Primus Medident Private Limited, buy the company report.
Shareholding
The shareholding of Primus Medident Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Primus Medident Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Primus Medident Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primus Medident Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Primus Medident Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Primus Medident Private Limited has 4 board changes on record since 2009: 3 appointments and 1 cessation. The latest: Jagvir Singh Yadav ceased to be Director on 21 Aug 2017.
AGM
Primus Medident Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Primus Medident Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Jagvir Singh Yadav ceased to be Director.
Appointed
Vaibhav Yadav was appointed as Director.
Appointed
Garima Yadav was appointed as Director.
Appointed
Mahinder Singh was appointed as Director.
Incorporation
15 Jan 2009
Primus Medident Private Limited was registered on 15 Jan 2009 with Roc Delhi I & aged 17 years 9 months as per MCA records.
Frequently asked questions
Primus Medident is an active private limited company based in New Delhi, Delhi, India. The company works in nursing, within the healthcare industry. It was incorporated on 15 January 2009 (17+ years old) and is registered under CIN U85100DL2009PTC186701.
Primus Medident has 3 current directors:
- Mahinder Singh - Director
- Garima Yadav - Director
- Vaibhav Yadav - Director
The latest financial statements of Primus Medident on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Primus Medident is U85100DL2009PTC186701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primus Medident was incorporated on 15 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Primus Medident by revenue are Total Health Pharmaceuticals Private Limited, Maurya Diagnostic Centre Private Limited, Sushrutha Facio Maxillary Services Private Limited, Leopath Wellness Labs Private Limited, Sequel Diagnostic Services Private Limited and 5 more, all in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Jagvir Singh Yadav ceased to be Director on 21 Aug 2017. Vaibhav Yadav was appointed as Director on 25 Feb 2017. Garima Yadav was appointed as Director on 15 Jan 2009. Primus Medident has 4 board changes on record in total.
Yes, Primus Medident is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-04-0018998).
The registered office of Primus Medident is at 125 Vardhman Plus City Mall Sector – 23 Dwarka, New Delhi, Delhi, India – 110075.
Primus Medident operates in the healthcare industry, in the nursing segment.
The compliance status of Primus Medident is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.